Spyglass Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Carvana
CVNA
|
+$67.2M |
| 2 |
Credo Technology Group
CRDO
|
+$59.8M |
| 3 |
Cadence Design Systems
CDNS
|
+$50.7M |
| 4 |
CoStar Group
CSGP
|
+$40.8M |
| 5 |
Fair Isaac
FICO
|
+$37.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EXAS
Exact Sciences
EXAS
|
+$127M |
| 2 |
Medpace
MEDP
|
+$46.4M |
| 3 |
Applovin
APP
|
+$34.8M |
| 4 |
Sweetgreen
SG
|
+$32.4M |
| 5 |
ACV Auctions
ACVA
|
+$30.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 45.44% |
| 2 | Consumer Discretionary | 12.16% |
| 3 | Industrials | 12.03% |
| 4 | Healthcare | 11.76% |
| 5 | Financials | 9.24% |
Similar funds
Spyglass Capital Management's Q4 2025 Portfolio in Review
As of Q4 2025, Spyglass Capital Management held 27 positions worth $2B, up 6.6% from $1.88B the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Spyglass Capital Management deployed $133M of net new capital in Q4 2025, opening 2 new positions and adding to 16 existing holdings. Its largest new stake was Carvana: 903,340 shares worth $76.2M.
By sector, the portfolio is most concentrated in Technology at 45% of assets, up from 41% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was Exact Sciences, an estimated $127M trimmed.
- Spyglass Capital Management's largest Q4 2025 buy was Carvana: 903,340 shares worth $76.2M.
- Spyglass Capital Management added most to Cadence Design Systems in Q4 2025, an estimated $50.7M increase.
- Spyglass Capital Management's biggest Q4 2025 reduction was Exact Sciences, cutting an estimated $127M.
- Spyglass Capital Management fully exited Sweetgreen in Q4 2025, selling an estimated $32.4M.
- Spyglass Capital Management's ten largest holdings make up 50% of its $2B portfolio in Q4 2025.
- Spyglass Capital Management opened 2 new positions and closed 2 in Q4 2025.
- Spyglass Capital Management's portfolio value rose 6.6% quarter-over-quarter to $2B.
Based on Spyglass Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.